Imaging Study Suggests Underlying TD Vulnerability, but Experts Raise Methodological Questions

Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina ShawCould at least some cases of tardive dyskinesia (TD) reflect an underlying brain vulnerability that antipsychotics expose or accelerate, instead of a straightforward drug effect? That’s the suggestion from a new imaging-based study published in Schizophrenia by researchers in Germany and Switzerland. But two psychiatric pharmacists expressed some skepticism.“I think we know that the pathophysiology of TD i